https://www.selleckchem.com/products/myci975.html
The aim of this study was to assess the performance of eight clinical risk prediction scores to identify individuals with systemic lupus erythematosus (SLE) at high cardiovascular disease (CVD) risk, as defined by the presence of atherosclerotic plaques. CVD risk was estimated in 210 eligible SLE patients without prior CVD or diabetes mellitus (female 93.3%, mean age 44.8 ± 12 years) using five generic (Systematic Coronary Risk Evaluation (SCORE), Framingham Risk Score (FRS), Pooled Cohort Risk Equations (ASCVD), Globorisk, Prospective
Like
Comment
Share
